Werkgroep Cardiologische centra Nederland

VICTORION-2 PREVENT (Follow-up)

A randomized double-blind, placebo controlled, multicenter trial, assessing the impact of Inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease
Medicine
Inclisiran
Population
ASCVD
Phase
III
Starting year
2021

Director of Study

drs. H.P. Swart (Cardioloog)
Sneek, D&A Research and Genetics